Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUC2-676 vs HUC2-676-R pharmacokinetics in healthy volunteers
NCT07337174Phase 1Not yet recruiting
- Sponsor
- Huons
- Start
- Jan 2026
- Primary completion
- Mar 2026
- Modality
- Peptides
01
Overview
Phase 1, randomised, open-label trial of HUC2-676 in obesity (2 arms), sponsored by Huons. Primary endpoints: Maximum Plasma Concentration at 72 hours and Area Under the Curve at 72 hours. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
HUC2-676
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07337174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07337174.